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Abstract
Background: Cigarette smoking has been associated with worse infertility treatment outcomes, yet some studies
have found null or inconsistent results.
Methods: We followed 225 couples who underwent 354 fresh non-donor assisted reproductive technology (ART)
cycles between 2006 and 2014. Smoking history was self-reported at study entry. We evaluated the associations
between smoking patterns and ART success using multivariable discrete time Cox proportional hazards models with
six time periods: cycle initiation to egg retrieval, retrieval to fertilization, fertilization to embryo transfer (ET), ET to
implantation, implantation to clinical pregnancy, and clinical pregnancy to live birth to estimate hazard ratios (HR)
and 95% CIs. Time-dependent interactions between smoking intensity and ART time period were used to identify
vulnerable periods.
Results: Overall, 26% of women and 32% of men reported ever smoking. The HR of failing in the ART cycle without
attaining live birth for male and female ever smokers was elevated, but non-significant, compared to never smokers
regardless of intensity (HR = 1.02 and 1.30, respectively). Female ever smokers were more likely to fail prior to oocyte
retrieval (HR: 3.37; 95% CI: 1.00, 12.73). Every one cigarette/day increase in smoking intensity for females was associated
with a HR of 1.02 of failing ART (95% CI: 0.97, 1.08), regardless of duration or current smoking status. Women with
higher smoking intensities were most likely to fail a cycle prior to oocyte retrieval (HR: 1.07; 95% CI: 1.00, 1.16).
Among past smokers, every additional year since a man had quit smoking reduced the risk of failing ART by 4%
(HR: 0.96; 95% CI: 0.91, 1.00) particularly between clinical pregnancy and live birth (HR: 0.86; 95% CI: 0.76, 0.96).
Conclusions: Female smoking intensity, regardless of current smoking status, is positively associated with the risk
of failing ART cycles between initiation and oocyte retrieval. In men who ever smoked, smoking cessation may
reduce the probability of failing ART, particularly between clinical pregnancy and live birth.
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Background
Tobacco is among the leading causes of death and
disability worldwide [1], with over 6 million people dying
of tobacco-related causes per year [2]. It is a common
exposure in the US, with smoking reported for approxi-
mately 25% of reproductive-aged women, 12% of women
during pregnancy [3], and 25% of men aged 25 to
44 years [4]. Cigarette smoke contains about 4000 com-
pounds that have been associated with increased risk of
cardiovascular disease, lung disease, cancer [5, 6] and
adverse reproductive outcomes [7, 8].
Previous studies have shown that a couple’s likelihood
of success when undergoing assisted reproduction varies
depending on their smoking history [9]. Female smoking
has been associated with poorer ovarian response
markers, lower oocyte counts, and lower rates of im-
plantation [10] and live birth [11, 12] following assisted
reproductive technology (ART). Male smoking has also
been associated with lower live birth rates [12], inde-
pendent of female smoking. To date, most studies have
been limited in their assessment of smoking history,
generally comparing “smokers” to “non-smokers” with-
out making clear distinctions among past and never
smokers and rarely taking into account smoking inten-
sity, duration or cessation. Furthermore none of the
previous studies have utilized methods which allow
distinction of smoking effects by stage of the ART cycle,
and thus have not always been able to account for early
failures, which may have resulted in contradictory
findings [13].
Thus it remains unclear whether characteristics of a
couple’s smoking history, such as duration and intensity
of smoking, the age at smoking initiation, and years
since smoking cessation could affect the probability of
succeeding at ART. To address this, we evaluated the as-
sociation of pre-treatment smoking patterns and infertil-
ity treatment outcomes in a prospective cohort of
couples undergoing ART at the Massachusetts General
Hospital (MGH) Fertility Center, using novel statistical
methods to allow for a changing effect of smoking on
ART failure across time periods within an ART cycle.
Methods
Study overview
Participants were couples enrolled in the Environment
And Reproductive Health (EARTH) study, an ongoing
prospective cohort study started in 2006 aimed at
identifying determinants of fertility among couples
presenting to the MGH Fertility Center (Boston, MA)
[14]. The study was approved by the Institutional Re-
view Boards of MGH and the Harvard T. H. Chan
School of Public Health. All participants provided
written informed consent.
Study population
Couples presenting to the MGH Fertility Center were
given information about the EARTH Study by the
medical team. Study personnel approached couples who
met the age requirements (18–46 years for women; 18–
55 years for men), and who initially planned to use their
own gametes for treatment. Approximately 60% of those
contacted participated in the study. Participants were in-
cluded in the main analysis if they underwent at least
one fresh non-donor ART cycle between 2006 and 2014
(n = 392). Due to our interest in smoking patterns
among couples, we excluded 156 women whose partner
had not yet enrolled or elected not to enroll in the
EARTH study. Some aspects differed in the excluded
couples compared to those included. On average, the
female partners from the excluded couples were slightly
older (36 vs. 35 years), had higher BMIs (25 vs.24 kg/
m2), had more pack-years of smoking (1.4 vs. 0.7 pack-
years), and were less likely to have completed at least a
college education (78% vs. 86%). The cycles from the
excluded couples were also more likely to fail prior to
embryo transfer (15% vs. 8%). After exclusions, 236 cou-
ples who underwent a total of 354 fresh non-donors
ART cycles were included in the analysis.
Smoking assessment
Participants were asked to report whether they had ever
smoked cigarettes (defined as smoking at least 1
cigarette/day for a year or at least 20 packs in their life-
time) in a brief staff-administered questionnaire. Individ-
uals reporting a positive smoking history were asked
about their age at initiation, current smoking status,
smoke inhalation practices, and the brand of cigarette
they used (including size, tobacco type, and filter). Cou-
ples reporting current use reported what day they had
their last cigarette, how many cigarettes they currently
smoke per day, average number of cigarettes smoked per
day over their years as a current smoker, and whether
they had ever quit for 6 months or more and, if yes, how
many years they quit. Former users reported how old
they were they quit smoking, if they quit in the last year,
the date, quantity of cigarettes smoked per day during
the period they smoked, and if before they quit there
were periods (≥6 months) when they didn’t smoke. The
total smoking duration was calculated in current users
by subtracting the age of smoking initiation from their
current age. In former smokers we subtracted the age of
smoking initiation from their age on cessation. For both we
subtracted their interim cessation periods from their total
smoking duration. Pack-years of smoking was calculated as:
Average number of cigarettes smoked a day
20 cigarettes per pack  Total smoking duration yearsð Þ
[15]. Questions on the use of other tobacco products (i.e.
cigars, pipes, chewing tobacco and snuff or dip tobacco)
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were included on the questionnaire, but due to their
infrequent use in our sample (<2% for cigars and <1% for
the rest), only cigarettes smoking was considered as an ex-
posure in our analyses.
Covariates
At enrollment, a brief nurse-administered questionnaire
was used to collect data on demographic characteristics,
medical history, and lifestyle factors. A trained research
study staff member measured each participant’s height
and weight.
ART Outcomes
Women underwent a pretreatment cycle of oral contra-
ceptives for 2–5 weeks to suppress ovulation before their
ART cycles, unless contraindicated. On day 3 of induced
menses, patients began controlled ovarian stimulation.
Women underwent one of three stimulation protocols
as clinically indicated: 1) luteal-phase GnRH agonist
protocol; 2) follicular-phase GnRH-agonist/flare proto-
col; or 3) GnRH-antagonist protocol. Patients were
monitored during gonadotropin stimulation for serum
estradiol and endometrial thickness through 2 days be-
fore egg retrieval. Human chorionic gonadotrophin was
administered 36 h before the scheduled egg retrieval
procedure to induce ovulation. Details of oocyte retrieval
have been previously described [16]. Embryologists clas-
sified oocytes as germinal vesicle, metaphase I, meta-
phase II (MII), or degenerated. Following retrieval,
couples underwent conventional insemination or intra-
cytoplasmic sperm injection (ICSI) for fertilization. We
defined successful implantation as a serum β-hCG level
>6 mIU/mL 15–20 days after egg retrieval, clinical preg-
nancy as the presence of an intrauterine pregnancy in
ultrasound, and live birth as the birth of a neonate at or
after 24 weeks of gestation. All clinical information was
abstracted from electronic medical records.
Statistical analysis
Both male and female participants were classified into
three categories: never, former, and current smokers
according to self-reported smoking status. We then
cross-classified couples into four categories according to
their ever smoking status. We evaluated the effect of
smoking intensity using the variables average cigarettes/
day and total years of smoking as continuous exposures.
Descriptive statistics were calculated for demographic
and reproductive characteristics according to current
smoking status prior to ART treatment. A Chi-square
test or Fisher’s exact test was used to test for differences
across categories for discrete variables and the Kruskal-
Wallis test for differences across categories for continu-
ous variables.
Multivariable Cox proportional hazards models for
discrete survival time were used to estimate the hazard
ratios (HRs) and 95% confidence intervals (CIs) for the
associations between smoking patterns and risk of failing
ART prior to live birth, as proposed by Maity [17] and
Missmer [18]. In all of these models, a robust sandwich
covariance estimate was used to account for the multiple
cycles per woman. HRs estimate the odds of failing an
ART cycle at any point, conditional on not failing at an
earlier moment during the same cycle. Women were
considered at risk of failing ART for the duration of their
initiated cycle until their specific point of failure. There
were six periods during which women could fail a cycle:
between (1) cycle initiation and oocyte retrieval, (2) re-
trieval and fertilization, (3) fertilization and embryo
transfer (ET), (4) ET and implantation, (5) implantation
and clinical pregnancy, and (6) between clinical preg-
nancy and live birth. Estimated probabilities of survival
for the average women in our cohort (according to mean
or reference levels for covariates other than smoking)
were used to construct survival curves across these
time points.
Confounding was evaluated through directed acyclic
graphs based on prior knowledge and descriptive statis-
tics in the study population. The multivariable models
were adjusted for age, BMI, protocol, educational level
and partner’s smoking history (never or ever smoker).
We centered smoking intensity, years of smoking dur-
ation and pack-years by the whole sample’s mean for
continuous analyses. For analysis of smoking history
(ever vs. never smoker), smoking status (never, former
and current smoker) and couple’s cross-classifications,
we further adjusted by centered pack-years. We analyzed
as continuous variables smoking intensity and duration
in the entire population years since smoking cessation
and age at smoking initiation among ever smokers (58
women and 71 men). Never smokers were assigned a
value of 0 average cigarettes/day and 0 years of total
smoking for the continuous analyses. Since in Massa-
chusetts insurance companies require current smokers
to have cotinine levels below the non-smoker reference
value for 2 months to provide authorization for IVF
coverage, we assigned a cessation time of 2 months for
current smokers. All results are presented as HRs for a 1
unit increase in the continuous exposure. We further ad-
justed the models for smoking intensity (cigarettes/day)
and smoking duration (years) using a binary variable for
self-reported current smoking status. Models for smok-
ing cessation and age at initiation were further adjusted
for pack-years. The model of age at smoking initiation
was also further adjusted for a binary variable for self-
reported current smoking-status. To evaluate whether
there were specific stages of the cycle which were more
vulnerable to the effects of smoking, we fit multivariate
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models with time-dependent interaction between the
discrete time periods and smoking exposures.
We also ran a variety of sensitivity analysis to address
potential issues related to misclassification of the expos-
ure, selection bias into the study, and model fitting. In
accordance with a prior methodological paper on
smoking and lung cancer [19], we conducted a sensitivity
analysis re-classifying the participant’s self-reported smoking
status according to their time of cessation in three discrete
categories: never smokers (self-reported never smokers),
former smokers (self-reported former smokers with > 2 years
of smoking cessation) and “clinically active smokers” (self-
reported current smokers and self-reported former smokers
with ≤ 2 years of smoking cessation). Also, in order to assess
the possibility of selection bias in our sample (due to the
exclusion of women who did not have a partner enrolled),
we conducted a sensitivity analysis including all woman
regardless of whether their partner was enrolled and
analyzed the association between smoking history and
probability of failing ART without adjusting for the
male partner’s smoking history. Finally, we performed
an analysis limited to the couple’s first cycle to address
the potential limitation of this model to account for the
imbalanced number of cycles per couple.
To illustrate the possible effect of survival bias, we used
generalized linear mixed models with random intercepts
to analyze the associations between smoking patterns and
oocyte yield (Poisson distribution and log link); endomet-
rial wall thickness and peak serum estradiol at trigger day
(binomial distribution and log link) among women who
underwent oocyte retrieval, and probability of live birth
per initiated cycle and per embryo transfer (binary distri-
bution and logit link). These results are presented as
population marginal means adjusted for covariates. All
analyses were conducted using the Statistical Analysis
System Software package SAS 9.4 (SAS Institute Inc.,
Cary, NC) and considered two-sided significance levels
< 0.05 as statistically significant.
Results
Our sample consisted mostly of non-Hispanic Caucasians
(86% of women; 88% of men) with a mean age of 34.8 and
36.6 years for female and male participants, respectively.
About 26% of women were self-reported ever smokers
(23% former and 3% current smokers); 32% of men were
ever smokers (24% former and 7% current smokers). On
average, women who ever smoked started smoking when
they were 17 years, smoked 6 cigarettes/day for 9 years,
and if they had quit, they did so 7.5 years before cycle ini-
tiation. Similarly, men who ever smoked started smoking
when they were an average of 18 years old, and on average
smoked 9 cigarettes per day for 12 years, and if they had
quit, they did so 6 years before cycle initiation. Men and
women who were current smokers were more likely to
have a partner who currently smoked and were less likely
to have a college education compared to never smokers
(Tables 1 and 2). Current smokers also reported smoking
for longer durations compared to former smokers.
Current male smoker were more likely to have undergone
reproductive tract surgery prior cycle initiation. Current
female smokers were more likely to have their first cycle
cancelled prior to embryo transfer and had higher baseline
FSH levels.
Smoking status of the female partner, the male partner,
and the cross-classified couple smoking status were un-
related to the risk of cycle failure (Table 3). The HR of
failing ART for female ever smokers compared to never
smokers was 1.30 (95% CI: 0.84, 2.02; P-Value =0.24)
and estimated HRs remained similar even after account-
ing for smoking intensity and duration. When evaluating
the effects of smoking during specific periods of poten-
tial ART failure, ever female smokers were marginally
more likely to fail prior to oocyte retrieval (HR: 3.57;
95% CI: 1.00, 12.73; P-Value = 0.05) but not during other
periods of the ART cycle. In the self-reported current
smoking status analysis, the HR of failing ART for
former and current female smokers was 1.23 (95% CI:
0.79, 1.91; P-Value = 0.35) and 2.41 (95% CI: 0.62, 9.39;
P-Value = 0.20) when compared to never smokers. Simi-
larly, current smokers (HR: 6.0; 95% CI: 0.96, 37.07; P-
Value = 0.05) and former smokers (HR: 2.05; 95% CI:
0.50, 8.34; P-Value = 0.32) were more likely to fail prior
to oocyte retrieval compared to never smokers but this
association was not significant for the other ART time
points and only borderline significant for current
smokers. Women whose male partners were former and
current smokers had no increased risk of failing ART
when compared to never smokers. In addition, couple
classifications in which either or both of the partners
ever smoked, as compared to couples in which neither
partner ever smoked, did not have an increase in risk of
cycle failure.
For the intensity and duration analyses (Table 4), a 1
cigarette/day increase in female smoking intensity was
associated with a 7% increased risk of failing at ART
(HR = 1.07, 95% CI: 0.97, 1.08; P-Value = 0.45) after fur-
ther adjustment for smoking duration and current smok-
ing status; while a 1 year increase in smoking duration
yielded a HR of 1.01 (95% CI: 0.97, 1.05 P-Value = 0.61)
after further adjustment for smoking intensity and
current smoking status. Greater intensity of female
smoking was associated with a borderline higher risk of
failing a cycle prior to oocyte retrieval (HR: 1.07; 95%
CI: 1.00, 1.16; P-Value = 0.07); In contrast smoking dur-
ation was not significantly related to the probability of
failing ART during any period of the ART cycle. Neither
time of cessation nor age of smoking initiation was sig-
nificantly associated with the risk of failing ART (Table 4).
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Table 1 Baseline characteristics of 225 couples from the EARTH study in relation to female smoking status
Female Smoking Status P-value a
Never smoker Former smoker Current smoker
Number of couples, n (%) 167 (74.2) 51 (22.7) 7 (3.1) <0.001
Total ART cycles, n (%) 249 (70.3) 93 (26.3) 12 (3.4) <0.001
Female Characteristicsb
Age, years 35 (32, 38) 34 (33, 37) 34 (29, 37) 0.89
Body Mass Index, kg/m2 22.6 (20.4, 26.3) 22.7 (21.5, 24.7) 25.7 (23.8, 28.2) 0.11
At least college education, n (%) 148 (88.6) 39 (76.5) 5 (71.4) 0.04
Non-Hispanic Caucasian, n (%) 143 (85.6) 43 (84.3) 7 (100) 0.74
Pack-years NA 1.6 (0.5, 4.6) 2.4 (1.0, 4.2) 0.65
Total smoking duration, years NA 9 (5, 13) 14 (8, 16) 0.08
Average cigarettes smoked NA 4.0 (1.5, 10.0) 5.0 (1.5, 7.0) 0.89
Age of smoking initiation, years NA 17 (15, 18) 18 (18, 20) 0.04
Total Smoking cessation, years NA 8.0 (5.0, 12.0) 0.2 (0.2, 0.2) <0.001
Exposed to passive smoking, n (%) 30 (18.0) 14 (27.5) 2 (28.6) 0.23
Male Partner Characteristics
Partner age, years 36 (33, 40) 35 (33, 40) 39 (35, 41) 0.40
Partner body mass index, kg/m2 26.9 (24.2, 29.3) 26.9 (24.5, 29.3) 27.9 (25.1, 28.3) 0.97
Partner former smoker, n (%) 38 (22.8) 16 (31.4) 1 (14.3) 0.44
Partner current smoker, n (%) 8 (4.8) 4 (7.8) 4 (57.1) <0.001
Baseline Reproductive Characteristics
Previous IUI, n (%) 71 (42.5) 19 (37.3) 2 (28.6) 0.70
Previous IVF, n (%) 40 (24.0) 8 (15.7) 1 (14.3) 0.51
ICSI, n (%) 83 (49.7) 31 (60.8) 4 (57.1) 0.37
Infertility diagnosis, n (%) 0.47
Male factor 55 (32.9) 20 (39.2) 4 (57.1)
Diminished ovarian reserve 9 (5.9) 3 (5.9) 1 (14.3)
Endometriosis 10 (6.0) 3 (5.9) 0 (0.0)
Ovulatory dysfunction 15 (9.0) 5 (9.8) 0 (0.0)
Tubal causes 11 (6.6) 8 (15.7) 1 (14.3)
Uterine causes 3 (1.8) 0 (0.0) 0 (0.0)
Unexplained 64 (38.3) 12 (23.5) 1 (14.3)
Initial treatment protocol, n (%) 0.69
Antagonist 21 (12.6) 5 (9.8) 1 (14.3)
Flare 17 (10.2) 8 (15.7) 0 (0.0)
Luteal phase agonist 129 (77.3) 38 (75.5) 6 (85.7)
Day 3 FSH levels, IU/L 6.6 (5.8, 8.0) 7.3 (6.0, 8.8) 8.1 (7.0, 8.3) 0.16
E2 Trigger levels, pmol/L 2126 (1632, 2639) 1828 (1459, 2532) 1798 (1540, 1953) 0.17
Day of embryo transfer, n (%) 0.01
No transfer 11 (6.6) 4 (7.8) 2 (28.6)
Day 2 4 (2.4) 5 (2.2) 0 (0.0)
Day 3 79 (47.6) 29 (56.9) 1 (14.3)
Day 5 72 (43.4) 13 (25.5) 4 (57.1)
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We found a borderline significant protective effect of smok-
ing cessation in ever-smoker males; for every additional
year since a male smoker quit, the risk of failing during an
ART cycle decreased by 4% (HR: 0.96; 95% CI: 0.91, 1.00;
P-Value <0.05) regardless of smoking duration and inten-
sity. This association was particularly pronounced for the
time period between clinical pregnancy and live birth (HR:
0.86; 95% CI: 0.76, 0.96; P-Value = 0.01).
Reclassification of smoking status by taking into ac-
count time since smoking cessation did not significantly
alter our results. For instance, compared to never
smokers, former smokers had a 23% increase in risk
(HR = 1.23,95% CI: 0.78, 1.95; P-Value = 0.37) while
“clinically active” smokers had a HR of 1.62 (95% CI:
0.70, 3.78; P-Value = 0.37) of failing at ART; similar to
the main analysis, the increased risk of failing at ART
was predominantly prior to oocyte retrieval (HR: 2.47;
95% CI: 1.27, 4.78; P-Value = 0.01) for “clinically active”
smokers. The sensitivity analysis including the women
without a male partner enrolled in the study provided
consistent results to those seem in the main sample.
Specifically, female ever smokers had a borderline sig-
nificant HR of 1.38 (95% CI: 0.99, 1.92; P-Value = 0.06)
compared to never smokers; also, this increased risk was
significantly higher for failing prior to oocyte retrieval
(HR: 2.45; 95% CI: 1.12, 5.36; P-Value = 0.02) and it was
also significant between embryo transfer and implant-
ation (HR: 1.63; 95% CI: 1.03, 2.58; P-Value = 0.04). An
increase of 1 cigarette/day produced an overall HR of
1.01 (95% CI: 0.97, 1.06; P-Value = 0.65) for failing at
ART and the HR was not significantly different according
to the particular moment of the cycle. Finally, sensitivity
analyses limited to the couple’s first cycle produced results
that were consistent with the main analysis, although with
loss of significance given the reduction in power: female
ever smokers had an HR of 1.34 (95% CI: 0.76, 2.34;
P-Value = 0.31) of failing ART compared to never
smokers and this increased risk was more pronounced
prior to oocyte retrieval (HR: 3.00; 95% CI: 0.56,
16.08; P-Value = 0.20) although these increases were
not statistically significant.
Given the observed relation between female smoking
and early ART failures, we analyzed the associations
between smoking patterns and oocytes counts among
women with successful egg retrieval using conventional
methods to illustrate the possible effect of survival bias.
In these models, self-reported current smokers appeared
to have a higher number of total and MII phased oocytes
retrieved than former and never smokers even after mul-
tivariable adjustment, although these differences did not
attain statistical significance (Additional file 1: Table S1);
however, 16.7% of cycles from self-reported current
smokers could not be included in this analysis because
they failed prior to retrieval compared to only 2.0% of
cycles from never smokers and 6.5% from former
smokers (Additional file 1: Table S1). We did not
observe associations with endometrial thickness or peak
estradiol levels. When we analyzed the associations be-
tween smoking patterns and live birth following ART
among the cycles of women undergoing an embryo
transfer and all initiated cycles, the predicted probability
of live birth was the lowest for current smokers in both
cases. However, the differences by smoking status for
women undergoing an embryo transfer were attenuated
compared to those observed taking into consideration
all initiated cycles (Additional file 2: Table S2). This was
to be expected as 25% of cycles from self-reported
current smokers failed prior to ET compared to only
6.8% of cycles from never smokers.
Discussion
In a prospective cohort of couples undergoing infertility
treatment with ART, we found that the female smoking
intensity was related to a higher risk of cycle failure prior
to oocyte retrieval, even after accounting for duration of
smoking and current smoking status. Our results suggest
that the effects of smoking on ovarian response to
controlled ovarian stimulation may persist after smoking
cessation. We also found a borderline protective effect for
male smoking cessation and cycle failure between clinical
pregnancy and live birth in former smokers. Our conven-
tional analysis highlighted the possibility that studies
ignoring failures prior to oocyte retrieval for intermediate
outcomes and failures prior to embryo transfer for clinical
outcomes may be susceptible to survival bias, possibly
explaining some inconsistencies in the literature of the
Table 1 Baseline characteristics of 225 couples from the EARTH study in relation to female smoking status (Continued)
Number of embryos transferred, n (%) <0.001
No transfers 11 (6.6) 4 (7.8) 2 (28.6)
1 embryo 42 (25.3) 2 (3.9) 2 (28.6)
2 embryos 81 (48.8) 41 (80.4) 3 (42.7)
3 or more embryos 32 (19.3) 4 (7.8) 0 (0.0)
aFrom Chi-square or Fisher test for discrete variables and Kruskal-Wallis for continuous variables
bContinuous variables are presented as median (25th percentile, 75th percentile) while categorical variables are presented as number of women (percent)
Abbreviations: ART Assisted reproductive technology, BMI Body mass index, E2 estradiol, FSH follicle stimulating hormone, IVF In-vitro fertilization, ICSI Intracytoplasmic
sperm injection, IUI intrauterine sperm insemination
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Table 2 Baseline characteristics of 225 couples from the EARTH study in relation to male smoking status
Male Smoking Status P –value
Never smoker Former smoker Current smoker
Number of couples, n (%) 154 (68.4) 55 (24.4) 16 (7.1) <0.001
Total ART cycles, n (%) 235 (66.4) 89 (25.1) 30 (8.5) <0.001
Male Characteristicsb
Age, years 35 (32, 40) 37 (34, 40) 37 (33, 39) 0.20
BMI, kg/m2 26.8 (24.3, 29.1) 27.4 (24.3, 30.0) 25.6 (23.4, 28.3) 0.33
At least college education, n (%) 111 (72.1) 33 (60.0) 7 (56.3) 0.15
Non-Hispanic Caucasian, n (%) 137 (89.0) 48 (87.3) 13 (81.3) 0.58
Pack-years NA 3.3 (1.1, 7.3) 7.0 (3.3, 8.7) 0.07
Total smoking duration, years NA 10 (5, 14) 17 (14, 19) 0.001
Average cigarettes smoked NA 6.0 (3.0, 12.0) 9.3 (4.8, 11.3) 0.68
Age of smoking initiation, years NA 18 (16, 20) 16 (15, 20) 0.22
Total Smoking cessation, years NA 4.0 (1.5, 7.8) 0.2 (0.2, 0.2) <0.001
Exposed to passive smoking, n (%) 24 (15.6) 14 (25.5) 7 (43.8) 0.01
Male Reproductive History
History of cryptorchidism, n (%) 10 (6.5) 2 (3.7) 2 (12.5) 0.42
History of varicocele, n (%) 16 (10.4) 4 (7.3) 2 (12.5) 0.90
History of reproductive surgery, n (%) 31 (20.1) 8 (14.6) 7 (43.8) 0.04
Female Partner Characteristics
Partner age, years 34 (32, 38) 35 (33, 38) 36 (33, 39) 0.47
Partner BMI, kg/m2 22.2 (20.7, 25.4) 23.8 (21.3, 27.7) 24.8 (20.5, 29.2) 0.11
Partner former smoker, n (%) 31 (20.1) 16 (29.1) 4 (25.0) 0.38
Partner current smoker, n (%) 2 (1.3) 1 (1.8) 4 (25.0) <0.001
Baseline Reproductive Characteristics
Previous IUI, n (%) 67 (43.5) 18 (32.7) 7 (43.8) 0.37
Previous IVF, n (%) 34 (77.9) 11 (20.0) 4 (25.0) 0.90
ICSI, n (%) 82 (53.3) 27 (49.1) 9 (56.3) 0.83
Infertility diagnosis, n (%) 0.53
Male factor 55 (35.7) 16 (29.1) 8 (50.0)
Diminished ovarian reserve 8 (5.2) 3 (5.5) 2 (12.5)
Endometriosis 6 (3.9) 6 (10.9) 1 (6.3)
Ovulatory dysfunction 13 (8.4) 7 (12.7) 0 (0.0)
Tubal Causes 13 (8.4) 5 (9.1) 2 (12.5)
Uterine Causes 2 (1.3) 1 (1.8) 0 (0.0)
Unexplained 57 (37.0) 17 (30.9) 3 (18.8)
Initial treatment protocol, n (%) 0.05
Antagonist 16 (10.4) 5 (9.1) 6 (37.5)
Flare 18 (11.7) 5 (9.1) 2 (12.5)
Luteal phase agonist 120 (77.9) 45 (82.8) 8 (50.0)
Day 3 FSH levels, IU/L 6.7 (5.8, 8.0) 6.6 (5.8, 8.2) 8.2 (7.3, 9.5) 0.004
E2 Trigger levels, pmol/L 2076 (1560, 2678) 2145 (1632, 2570) 1761 (1225, 2311) 0.27
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effects of smoking on human fertility, such as a higher
number of oocytes or no differences in clinical outcomes
comparing current to never smokers [13].
Despite the low prevalence of current smoking in our
cohort, our results do suggest that female smoking is
detrimental to overall ART success. These results are in
accordance with previous cohort studies and meta-
analyses which reported lower probabilities of implant-
ation, clinical pregnancy and live birth following ART in
smokers compared to never smokers [9, 12, 20, 21].
Table 2 Baseline characteristics of 225 couples from the EARTH study in relation to male smoking status (Continued)
Day of embryo transfer, n (%) 0.90
No transfer 12 (7.8) 2 (7.3) 1 (6.3)
Day 2 7 (4.6) 1 (1.8) 1 (6.3)
Day 3 71 (46.4) 29 (52.7) 9 (56.3)
Day 5 63 (41.2) 21 (38.2) 5 (31.3)
Number of embryos transferred, n (%) 0.90
No transfer 12 (7.8) 2 (7.3) 1 (6.3)
1 embryo 34 (22.2) 8 (14.6) 4 (25.0)
2 embryos 83 (54.3) 34 (61.8) 8 (50.0)
3 or more embryos 24 (15.7) 9 (16.4) 3 (18.8)
aFrom Chi square or Fisher test for discrete variables and Kruskal-Wallis for continuous variables
bContinuous variables are presented as median (25th percentile, 75th percentile) while categorical variables are presented as number of women (percent)
Abbreviations: ART Assisted reproductive technology, BMI Body mass index, E2 estradiol, FSH Follicle stimulating hormone, IVF In-vitro fertilization, ICSI Intracytoplasmic
sperm injection, IUI Intrauterine sperm insemination
Table 3 Estimated cumulative probabilities of live birth and corresponding hazard ratios of failing at ART by discrete smoking
patterns (EARTH study, N = 225 couples, 354 ART cycles)
Number of Couples/Cycles Estimated cumulative probability




Female Smoking History 0.24
Never Smoker 167/249 54.2 (45.8, 64.0) 1.00 (REF)
Ever Smoker 58/105 45.0 (32.8, 61.8) 1.30 (0.84, 2.02)
Female Smoking Status 0.35
Never Smoker 167/249 54.1 (45.7, 63.9) 1.00 (REF)
Former Smoker 51/93 46.9 (34.5, 63.9) 1.23 (0.79, 1.91)
Current Smoker 7/12 22.7 (5.6, 92.0) 2.43 (0.64, 9.39)
Male Smoking History 0.93
Never Smoker 154/235 54.0 (46.6, 68.4) 1.00 (REF)
Ever Smoker 71/119 53.2 (43.1, 65.7) 1.02 (0.64, 1.63)
Male Smoking Status 0.75
Never Smoker 154/235 54.3 (45.7, 64.6) 1.00 (REF)
Former Smoker 55/89 56.4 (44.6, 71.5) 0.94 (0.55, 1.61)
Current Smoker 16/30 46.7 (30.6, 72.7) 1.25 (0.69, 2.25)
Couples Ever Smoking Status 0.59
Female and Male Never Smokers 121/172 54.7 (45.7, 65.4) 1.00 (REF)
Female Never Smoker, Male Ever Smoker 46/77 50.7 (38.4, 67.0) 1.12 (0.69, 1.84)
Female Ever Smoker, Male Never Smoker 33/63 42.2 (28.7, 62.0) 1.43 (0.85, 2.41)
Female and Male Ever Smokers 25/42 47.5 (31.8, 70.8) 1.24 (0.62, 2.46)
All estimates were calculated from a discrete time Cox proportional Hazard models adjusting for female age (centered continuous) and BMI (continuous);
induction protocol (categorical); female educational status (categorical); centered pack-years history (centered continuous) and partner’s smoking
status (categorical)
aEstimates of cumulative probability of not failing ART cycle are given for the average couple in our cohort (e.g. female age (34.8 years) and BMI (23.8 kg/m2);
induction protocol (luteal agonist); female educational status (more than college); centered pack-years history (0.93 packs-years for women; 2.47 packs-years for
men) and partner’s smoking status (never smoker)
bP-Value is testing for any difference across categories of exposure
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Similar to our findings, many of these previous studies
also found that female smokers were more likely to fail
before an embryo transfer [12, 21, 22]. The higher odds
of failing between cycle initiation and oocyte retrieval
could imply that cigarette smoke disrupts the response
to controlled ovarian hyper stimulation protocols or dis-
rupts the ovary itself. This mechanism could be related
to findings in animal models, in which cigarette smoke
has been found to alter the serum levels of sex hormones
and gametogenesis [23, 24]. Although this mechanism
accounts only for contemporaneous exposures there
seems to be a relation between lower fecundity and cumu-
lative smoking exposure in epidemiological studies [25].
Other epidemiological studies have shown that current
smokers were more likely to have worse ovarian stimula-
tion outcomes compared to never smokers [26, 27]. Our
findings also suggest an increased risk of failure at im-
plantation that may have been underpowered in our study,
as further evidenced by the results of the second sensitiv-
ity analysis which included a larger sample of women.
Not all epidemiological studies have found negative as-
sociations between smoking and ART success [13, 28]. Al-
though differences in study design and power may have
influenced these results, these studies also tended to
analyze clinical outcomes only among cycles reaching the
point of embryo transfer. Due to the effects of smoking on
early ART outcomes (e.g. response to controlled ovarian
stimulation), restricting analyses to only cycles with
embryo transfer creates a selection bias in which only the
women who survived until then are included, biasing the
observed burden of smoking downwards [29] even despite
the well-recognized associations between smoking and
miscarriage, stillbirth and neonatal death [30]. When we
analyzed the association between smoking patterns and
live birth per embryo transfer (as opposed to per initiated
cycle; Additional file 2: Table S2), we illustrated how this
issue may be at play. We also found paradoxical results
when we evaluated the association between smoking pat-
terns and oocyte counts among women with successful
egg retrieval, as current smokers appeared to yield as
many oocytes compared to former and never smokers.
However, this association appeared to be largely driven by
the 12% of cycles from smokers that failed prior to egg
retrieval which was more than double the percentage of
failures from never (2.0%) and former smokers (6.3%).
Future observational studies should use the appropriate
statistics to account for these effects, particularly when ex-
posures may exert effects early in gestation.
Other than a possible beneficial effect of smoking cessa-
tion among male ever-smokers, we did not observe any
significant associations when studying male smoking pat-
terns and ART outcomes. Nevertheless, male smoking has
been associated with lower semen quality parameters [31]
and live birth rates [22] in other epidemiological studies.
While our analyses were restricted by power, the fact that
former male smokers seemed to more quickly benefit
Table 4 Hazard ratios for failing ART by continuous smoking patterns (EARTH study, N = 225 couples, 354 ART cycles)
Smoking Pattern Adjusted Hazard Ratio (95% CI) P-Value
Female Smoking Intensity and Durationa
Per 1 additional cigarette per day 1.02 (0.97, 1.08) 0.45
Per 1 additional year of smoking 1.01 (0.97, 1.05) 0.68
Female Smoking Cessationb
Per 1 additional year of smoking cessation 1.01 (0.95, 1.08) 0.69
Female Age of Smoking Initiationc
Per 1 additional year later smoking initiation 0.90 (0.79, 1.02) 0.11
Male Smoking Intensity and Durationa
Per 1 additional cigarette per day 0.99 (0.97, 1.01) 0.36
Per 1 additional year of smoking 1.01 (0.99, 1.04) 0.25
Male Smoking Cessationb
Per 1 additional year of smoking cessation 0.96 (0.91, 1.00) 0.05
Male Age of Smoking Initiationc
Per 1 additional year later smoking initiation 1.04 (0.91, 1.19) 0.58
aIncluded all couples and cycles (N = 354 cycles). Data is presented as the cumulative hazard ratio for failing ART at any point per 1 unit increase of smoking
intensity (continuous, centered average cigarettes/day) and total years of smoking (continuous, centered years). The model was adjusted for female age and BMI,
protocol, educational status, current smoking status and partner’s smoking status
bLimited to ever smokers only (N = 105 cycles for women; N = 119 cycles for men). Data is presented as the cumulative hazard ratio for failing ART at any point
per 1 unit increase of smoking cessation (centered, continuous years). The model was adjusted for female age and BMI, protocol, educational status, pack-years
history and partner’s smoking status
cLimited to ever smokers only (N = 105 cycles for women; N = 119 cycles for men). Data is presented as the cumulative hazard ratio for failing ART at any point per
1 unit increase of smoking age at initiation (centered, continuous years). The model was adjusted for female age and BMI, protocol, educational status, pack-years
history, current smoking status and partner’s smoking status
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from smoking cessation could be explained by the biology
of sperm division and differentiation. The mechanism for
the observed reduction in cycle failure between clinical
pregnancy and live birth due to paternal smoking cessa-
tion could be due to lower maternal exposure to second
hand smoking and/or a direct paternal exposure [32], al-
though the exact mechanisms remain obscure.
Our study has certain limitations. Due to our design, it
may not be possible to extrapolate our results to the general
population. However, our cohort of men and women are
similar to the population of infertility patients nationwide
[33] suggesting that our results might be representative of
other couples undergoing ART. While we lacked specific
information on the women who declined to participate in
the EARTH study, we had a similar smoking prevalence as
other ART cohorts in the US [21]. Furthermore, in a previ-
ous study on semen quality from MGH, we found that men
who refused to participate were comparable to the men
who did participate in terms of baseline characteristics [34].
This suggests that the likelihood of selection bias in our
study (e.g. smoking men and women being less likely to
participate) is low. The women excluded had different base-
line characteristics than the included sample; however, our
results were similar after performing a sensitivity analysis
among all EARTH women and, in fact, some associations
gained significance with this increase in power. Another
generalizability concern is that in Massachusetts, insurance
companies will generally not allow current smokers to have
authorization for IVF coverage until cotinine levels are
below the non-smoker reference value for 2 months.
Therefore self-reported current smokers might not have
been smoking for the past two months, which might have
attenuated the magnitude of associations towards the null.
To address this we assumed a conservative cessation time
of at least 2 months for current smokers when modeling
time of smoking cessation a continuous exposure. Smoking
history was assessed through self-report in our population
as opposed to more objective markers like cotinine. While
it is possible there was some misclassification of current
smokers due to its subjectivity, a person’s self-report of
smoking is considered reliable [35]. To minimize the pos-
sible effect of passive smoking, we adjusted for the partner’s
smoking history. Although our survival models can account
for multiple cycles per women, they are unable to account
for the imbalance in number of cycles per couple (e.g.
women with more cycles are more likely to fail) [17], yet
even when we restricted the analysis to just the first cycle
per couple the results were similar. Residual and unmeas-
ured confounding is always possible as this was an observa-
tional cohort study; however, we attempted to minimize
this by adjusting for number of demographic and lifestyle
factors and focusing on a couple analyses. Our main
limitation was the small numbers of former and current
smokers, reducing our power to detect associations.
Also, the subjects who did smoke reported being mostly
“light” or “moderate” smokers in clinical terms. Our study
strengths include our prospective design, our detailed
assessment of smoking history, and our ability to account
for many confounders including the partner’s smoking.
Conclusions
Female smoking intensity was positively associated with
the risk of failing in ART cycles between cycle initiation
and oocyte retrieval. Among former male smokers, every
additional year of smoking cessation was associated with
a slightly decreased risk of failing at ART between
clinical pregnancy and live birth. Future studies should
further investigate the long-term effects of smoking
intensity on reproductive potential and take care to
use the appropriate analytical approaches to account
for failures at early stages of reproduction to reduce
the likelihood of survivor bias.
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